KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
This survey shows that companies have embarked on a journey of continuous improvement. This includes technical aspects and methodology, but also education and communication to support wider embedding across the firm.
Related links
RSS feeds
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.